TMDX – transmedics group, inc. (US:NASDAQ)
Stock Stats
News
TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Morgan Stanley from $123.00 to $135.00. They now have an "equal weight" rating on the stock.
TransMedics to Participate in the Piper Sandler 37th Annual Healthcare Conference
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
TransMedics Group (NASDAQ:TMDX) had its price target lowered by analysts at Piper Sandler from $145.00 to $140.00. They now have an "overweight" rating on the stock.
TransMedics Group (NASDAQ:TMDX) had its "buy" rating reaffirmed by analysts at Canaccord Genuity Group Inc..
Form 4 TransMedics Group, Inc. For: Dec 04 Filed by: Hernandez Gerardo
Form 4 TransMedics Group, Inc. For: Dec 03 Filed by: Weill David
Form 144 TransMedics Group, Inc. Filed by: Weill David
Form 4 TransMedics Group, Inc. For: Nov 25 Filed by: Ranganath Anil P.
Form 144 TransMedics Group, Inc. Filed by: Ranganath Anil P.
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.